Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor

a contemporary single-institution review

Matias Bruzoni, Purvi Parikh, Rolando Celis, Chandrakanth Are, Quan P Ly, Jane L Meza, Aaron R. Sasson

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Pancreatic nonfunctioning neuroendocrine tumors (PNFNETs) are an uncommon malignancy and often present with metastatic disease. There is a lack of information on the management of the primary tumor in patients who present with unresectable synchronous hepatic metastases. Methods: A retrospective review (2001-2008) of PNFNETs was conducted. Patients were divided into 3 groups: PNFNET without evidence of hepatic metastasis (group A), PNFNET with metastatic disease involving less than 50% of the liver (group B), and PNFNET with metastatic disease involving more than 50% of the liver (group C). Clinical data and outcomes were analyzed. Results: Thirty-five patients with PNFNET were identified (group A = 15, group B = 11, group C = 9). Resection of the pancreatic tumor was performed in 26 patients. With a mean follow-up period of 30 months, death from disease progression occurred in 1 patient in group A, none in group B, and in 7 in group C. Conclusions: In selected patients, resection of the primary pancreatic tumor even in the setting of unresectable but limited hepatic metastases may be indicated.

Original languageEnglish (US)
Pages (from-to)376-381
Number of pages6
JournalAmerican journal of surgery
Volume197
Issue number3
DOIs
StatePublished - Mar 1 2009

Fingerprint

Neuroendocrine Tumors
Liver
Neoplasms
Neoplasm Metastasis
Information Management
Disease Progression

Keywords

  • Pancreatic endocrine tumors
  • Pancreatic neoplasm
  • Pancreatic surgery

ASJC Scopus subject areas

  • Surgery

Cite this

Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor : a contemporary single-institution review. / Bruzoni, Matias; Parikh, Purvi; Celis, Rolando; Are, Chandrakanth; Ly, Quan P; Meza, Jane L; Sasson, Aaron R.

In: American journal of surgery, Vol. 197, No. 3, 01.03.2009, p. 376-381.

Research output: Contribution to journalArticle

@article{895483a1cd4641dfb8407b65a16813ab,
title = "Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor: a contemporary single-institution review",
abstract = "Background: Pancreatic nonfunctioning neuroendocrine tumors (PNFNETs) are an uncommon malignancy and often present with metastatic disease. There is a lack of information on the management of the primary tumor in patients who present with unresectable synchronous hepatic metastases. Methods: A retrospective review (2001-2008) of PNFNETs was conducted. Patients were divided into 3 groups: PNFNET without evidence of hepatic metastasis (group A), PNFNET with metastatic disease involving less than 50{\%} of the liver (group B), and PNFNET with metastatic disease involving more than 50{\%} of the liver (group C). Clinical data and outcomes were analyzed. Results: Thirty-five patients with PNFNET were identified (group A = 15, group B = 11, group C = 9). Resection of the pancreatic tumor was performed in 26 patients. With a mean follow-up period of 30 months, death from disease progression occurred in 1 patient in group A, none in group B, and in 7 in group C. Conclusions: In selected patients, resection of the primary pancreatic tumor even in the setting of unresectable but limited hepatic metastases may be indicated.",
keywords = "Pancreatic endocrine tumors, Pancreatic neoplasm, Pancreatic surgery",
author = "Matias Bruzoni and Purvi Parikh and Rolando Celis and Chandrakanth Are and Ly, {Quan P} and Meza, {Jane L} and Sasson, {Aaron R.}",
year = "2009",
month = "3",
day = "1",
doi = "10.1016/j.amjsurg.2008.11.005",
language = "English (US)",
volume = "197",
pages = "376--381",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Management of the primary tumor in patients with metastatic pancreatic neuroendocrine tumor

T2 - a contemporary single-institution review

AU - Bruzoni, Matias

AU - Parikh, Purvi

AU - Celis, Rolando

AU - Are, Chandrakanth

AU - Ly, Quan P

AU - Meza, Jane L

AU - Sasson, Aaron R.

PY - 2009/3/1

Y1 - 2009/3/1

N2 - Background: Pancreatic nonfunctioning neuroendocrine tumors (PNFNETs) are an uncommon malignancy and often present with metastatic disease. There is a lack of information on the management of the primary tumor in patients who present with unresectable synchronous hepatic metastases. Methods: A retrospective review (2001-2008) of PNFNETs was conducted. Patients were divided into 3 groups: PNFNET without evidence of hepatic metastasis (group A), PNFNET with metastatic disease involving less than 50% of the liver (group B), and PNFNET with metastatic disease involving more than 50% of the liver (group C). Clinical data and outcomes were analyzed. Results: Thirty-five patients with PNFNET were identified (group A = 15, group B = 11, group C = 9). Resection of the pancreatic tumor was performed in 26 patients. With a mean follow-up period of 30 months, death from disease progression occurred in 1 patient in group A, none in group B, and in 7 in group C. Conclusions: In selected patients, resection of the primary pancreatic tumor even in the setting of unresectable but limited hepatic metastases may be indicated.

AB - Background: Pancreatic nonfunctioning neuroendocrine tumors (PNFNETs) are an uncommon malignancy and often present with metastatic disease. There is a lack of information on the management of the primary tumor in patients who present with unresectable synchronous hepatic metastases. Methods: A retrospective review (2001-2008) of PNFNETs was conducted. Patients were divided into 3 groups: PNFNET without evidence of hepatic metastasis (group A), PNFNET with metastatic disease involving less than 50% of the liver (group B), and PNFNET with metastatic disease involving more than 50% of the liver (group C). Clinical data and outcomes were analyzed. Results: Thirty-five patients with PNFNET were identified (group A = 15, group B = 11, group C = 9). Resection of the pancreatic tumor was performed in 26 patients. With a mean follow-up period of 30 months, death from disease progression occurred in 1 patient in group A, none in group B, and in 7 in group C. Conclusions: In selected patients, resection of the primary pancreatic tumor even in the setting of unresectable but limited hepatic metastases may be indicated.

KW - Pancreatic endocrine tumors

KW - Pancreatic neoplasm

KW - Pancreatic surgery

UR - http://www.scopus.com/inward/record.url?scp=60549095160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549095160&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2008.11.005

DO - 10.1016/j.amjsurg.2008.11.005

M3 - Article

VL - 197

SP - 376

EP - 381

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 3

ER -